Clinical value of TSH-stimulated thyroglobulin in evaluation of metastasis from differentiated thyroid carcinoma after 131I treatment

被引：0
|
作者：
李夏黎 [1 ]
机构：
[1] Dept Nucl Med,Henan Prov People’s Hosp & People’s Hosp,Zhengzhou Univ
来源：
China Medical Abstracts (Internal Medicine) | 2017年 / 34卷 / 02期
关键词：
TSH; from; Clinical value of TSH-stimulated thyroglobulin in evaluation of metastasis from differentiated thyroid carcinoma after; I treatment; in; of;
D O I：
暂无
中图分类号：
R736.1 [甲状腺肿瘤];
学科分类号：
100214 ;
摘要：
Objective To investigate the critical value of TSHstimulated Tg(sTg)in the diagnosis of metastasis from DTC,and to evaluate the diagnostic value of the ratio of sTg to suppressed Tg(sTg/sup-pressed Tg).Methods A total of 330 post-operative DTC patients(87 males,243females,age range:12—70 years)who underwent thyroid remnant ablation from August 2008 to December2014 were retrospectively reviewed.Their serum Tg Ab
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] Prognostic value of initial TSH-stimulated thyroglobulin in differentiated thyroid cancer
    Kelly, Antony
    Kwiatkowski, Fabrice
    Bertrand, Sophie
    Aubert, Bernadette
    Cachin, Florent
    Merlin, Charles
    Gauthe, Mathieu
    Mestas, Danielle
    Dejax, Catherine
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [2] Empiric 131I Treatment of High Thyroglobulin Levels in Differentiated Thyroid Carcinoma After Remmant Ablation
    Kalender, E.
    Elboga, U.
    Celen, Y.
    Demir, H.
    Sahin, E.
    Yilmaz, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S503 - S503
  • [3] EMPIRIC 131I TREATMENT OF HIGH THYROGLOBULIN LEVELS IN DIFFERENTIATED THYROID CARCINOMA AFTER REMNANT ABLATION
    Kalender, Ebuzer
    Elboga, Umut
    Celen, Y. Zeke
    Demir, H. Deniz
    Sahin, Ertan
    Karacavus, Seyhan
    [J]. ACTA MEDICA MEDITERRANEA, 2014, 30 (02): : 503 - 507
  • [4] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
  • [5] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Zerva, C.
    Koutsikos, J.
    Palestidis, C.
    Kounadi, E.
    Gerali, S.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (04): : 348 - 354
  • [6] 18F-FDG PET-CT in differentiated thyroid carcinoma with negative 131I post-therapy whole body scan and elevated TSH-stimulated thyroglobulin
    Salvatori, M.
    Mazza, R.
    Baldari, G.
    Basile, P.
    Maussier, M. L.
    Perotti, G.
    Giordano, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S266 - S266
  • [7] Diagnostic value of serum preablative TSH-stimulated thyroglobulin (Tg), Tg/24h 131I neck uptake (RAIU) ratio, and Tg/(RAIUxTSH) ratio in patients with differentiated thyroid carcinoma (DTC)
    Salvatori, M.
    Mazza, R.
    Castaldi, P.
    Festa, A.
    Maussier, M. L.
    Perotti, G.
    Giordano, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S223 - S223
  • [8] The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial 131I therapy
    van Dijk, D.
    Plukker, J. T. M.
    van der Horst-Schrivers, A. N. A.
    Jansen, L.
    Brouwers, A. H.
    Muller-Kobold, A.
    Sluiter, W. J.
    Links, T. P.
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 74 (01) : 104 - 110
  • [9] Management of differentiated thyroid carcinoma by serum thyroglobulin and 131I scintigraphy after recombinant human TSH and 99mTc-Sestamibi
    Villa, G
    Giusti, M
    Zoccola, R
    Guazzini, B
    Molinari, E
    Castagnola, F
    Bertolazzi, L
    Minuto, F
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1206 - 1206
  • [10] 131I treatment for brain metastases from differentiated thyroid carcinoma
    YU Yong-Li
    [J]. Nuclear Science and Techniques, 2004, (04) : 223 - 226
12345